Overview of efficacy, side effects, and key challenges GLP-1 receptor agonists such as semaglutide and liraglutide, as well as combination agents like tirzepatide (which adds glucose-dependent insulinotropic polypeptide receptor agonism)all hereafter referred to as GLP-1s for brevityare effective new agents for obesity treatment which demonstrate weight reduction, weight maintenance, and reduced morbidity and mortality
We encourage patients to consult with our experienced healthcare providers to explore how Semaglutide GLP-1, alongside lifestyle changes, can be part of an effective strategy for achieving and maintaining a healthy weight
Understanding the clinical significance of each category helps patients and prescribers evaluate the platform's risk profile
Recognizing these distinctions can help inform evaluation of available options
Besides appetite signaling in the brain, what second mechanism does the post credit for prolonged fullness